Length of stay and survival after intensive care for severe Pneumocystis carinii pneumonia. A prospective study. California Collaborative Treatment Group.
Survival rates for persons receiving intensive care for Pneumocystis carinii pneumonia have improved. However, the utility of prolonged intensive care for patients who do not show initial improvement remains unclear. We assessed survival in a nested cohort study of patients receiving intensive care while participating in a randomized trial of early adjunctive corticosteroids for Pneumocystis pneumonia. Twenty-eight of 251 (11 percent) participants were admitted to an intensive care unit. Fourteen (50 percent) of these were discharged alive from the intensive care unit and 11 (39 percent) were discharged alive from the hospital. Survivors and nonsurvivors were similar demographically and with respect to treatment received but differed in the mean days of intensive care received (4.5 vs 8.6 [p = 0.02]). The conditional probability surviving to hospital discharge after intensive care dropped steadily from 39 percent at intensive care unit admission to 17 percent after one week and to 0 percent after two weeks.
Bozzette
S A
SA
Division of Infectious Diseases, University of California, San Diego.
Feigal
D
D
Chiu
J
J
Gluckstein
D
D
Kemper
C
C
Sattler
F
F
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D003422:Critical Care; D015658:HIV Infections / Q000150:complications; D006801:Humans; D007902:Length of Stay; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000401:mortality / Q000628:therapy*; D011446:Prospective Studies; D015996:Survival Rate
D000305:Adrenal Cortex Hormones